Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects

BenzingaAug 8 11:51 ET

Looking Into Merck & Co's Recent Short Interest

BenzingaAug 8 11:30 ET

Merck Ends Trial Evaluating Lung Cancer Treatment Following Committee Recommendation

WSJAug 8 07:38 ET

Merck Halts Phase 3 Trial of Lung Cancer Combination Therapy

MT NewswiresAug 8 07:23 ET

Merck Lung Cancer Combo Therapy Fails in Phase 3 Trial

Seeking AlphaAug 8 07:09 ET

Merck Says It's Discontinuing a Late-stage Trial of a Lung Cancer Treatment After High Number of Adverse Events

MarketWatchAug 8 07:09 ET